Mp. Targett et al., FAILURE TO ACHIEVE REMYELINATION OF DEMYELINATED RAT AXONS FOLLOWING TRANSPLANTATION OF GLIAL-CELLS OBTAINED FROM THE ADULT HUMAN BRAIN, Neuropathology and applied neurobiology, 22(3), 1996, pp. 199-206
The ability of transplanted glial cells to myelinate axons in experime
ntal animals offers the prospect that it may be possible to achieve re
myelination in human demyelinating disease by the implantation of olig
odendrocyte lineage cells. Autologous normal white matter could repres
ent a potential source of cells whose use would avoid tissue rejection
and overcome ethical and practical constraints associated with the us
e of fetal tissue. To determine the remyelinating potential of cells i
solated from adult human CNS, a cell preparation prepared from adult h
uman white matter which contained 56% oligodendrocytes, 3% preoligoden
drocytes and 1% precursor cells was transplanted into non-repairing de
myelinating lesions in immunosuppressed rats created by the injection
of ethidium bromide into x-irradiated spinal cord white matter, The ex
tent of remyelination was examined 3 and 5 weeks after transplantation
, Although the transplanted oligodendrocytes survived in the area of d
emyelination, associated with demyelinated axons and produced myelin m
embranes, no myelin sheaths were produced and there was no evidence of
cell migration or division, The failure of human oligodendrocytes to
form myelin sheaths may reflect the poor remyelinating potential of po
st mitotic oligodendrocytes, and the failure of the small number of co
-transplanted bipotential oligodendrocyte progenitor cells to differen
tiate and myelinate axons may be a consequence of lack of appropriate
environmental factors within the rat lesion required for expansion and
differentiation of these cells.